Skip to main content
Premium Trial:

Request an Annual Quote

New Products: IBM and CLC Bio's Analysis Platform; Life Tech's Oncomine

Premium

IBM and CLC bio have launched an analysis platform that combines CLC bio's Genomics Server software and Genomics Workbench software with IBM hardware.

The companies are offering three versions for small, medium, and large analysis pipelines. The small configuration comes with 48 CPU cores and 192 GBs of memory, the medium version with 96 CPU cores and 396 GBs of memory, and the large version with 192 CPU cores and 768 GBs of memory.


Life Technologies' Ion Torrent has launched Oncomine Gene Browser and Ion Reporter Oncomine.

Oncomine Gene Browser enables researchers to characterize genes of interest across multiple parameters, including gene expression, DNA copy number, and mutation data, and is geared toward researchers working with small numbers of genes.

The Ion Reporter Oncomine workflow provides access to curated next-generation sequencing data from 4,000 matched tumor and normal pairs and is designed to assist with interpreting variants from data obtained on the Ion Torrent sequencing platforms. It will be available at no charge for an introductory period.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.